Literature DB >> 20566994

Dosing of a phase I study of KW-0761, an anti-CCR4 antibody, for adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.

Ritsuro Suzuki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20566994     DOI： 10.1200/JCO.2010.29.7242

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Newly emerging therapies targeting viral-related lymphomas.

Authors:  Juan Carlos Ramos; Izidore S Lossos
Journal:  Curr Oncol Rep       Date:  2011-10       Impact factor: 5.075

Review 2.  Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.

Authors:  Ryan A Wilcox
Journal:  Am J Hematol       Date:  2015-11-26       Impact factor: 10.047

Review 3.  Targets, Toxins, and T Cells--a Review of New Monoclonal Antibodies in the Treatment of Peripheral T Cell Lymphomas.

Authors:  Jonathan Hebb; Holbrook Kohrt
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 4.213

4.  Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.

Authors:  Alexandra C Hristov; Trilokraj Tejasvi; Ryan A Wilcox
Journal:  Am J Hematol       Date:  2021-08-02       Impact factor: 13.265
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.